相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Synthetic Glabridin Derivatives Inhibit LPS-Induced Inflammation via MAPKs and NF-κB Pathways in RAW264.7 Macrophages
Jaejin Shin et al.
MOLECULES (2023)
Discovery and preclinical efficacy of HSG4112, a synthetic structural analog of glabridin, for the treatment of obesity
Leo Sungwong Choi et al.
INTERNATIONAL JOURNAL OF OBESITY (2021)
Pharmacological properties of glabridin (a flavonoid extracted from licorice): A comprehensive review
Chun-xiao Li et al.
JOURNAL OF FUNCTIONAL FOODS (2021)
Species Differences in Stereoselective Pharmacokinetics of HSG4112, A New Anti-Obesity Agent
In Yong Bae et al.
PHARMACEUTICS (2020)
Challenges and Recent Progress in Oral Drug Delivery Systems for Biopharmaceuticals
Bahman Homayun et al.
PHARMACEUTICS (2019)
Preclinical toxicity and pharmacokinetics of a new orally bioavailable flubendazole formulation and the impact for clinical trials and risk/benefit to patients
Sophie Lachau-Durand et al.
PLOS NEGLECTED TROPICAL DISEASES (2019)
Approaches to intravenous clinical pharmacokinetics: Recent developments with isotopic microtracers
Graham Lappin
JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Insoluble drug delivery strategies: review of recent advances and business prospects
Sandeep Kalepu et al.
ACTA PHARMACEUTICA SINICA B (2015)
Hypoglycemic effects of glabridin, a polyphenolic flavonoid from licorice, in an animal model of diabetes mellitus
Feihua Wu et al.
MOLECULAR MEDICINE REPORTS (2013)
Practical and Efficient Strategy for Evaluating Oral Absolute Bioavailability with an Intravenous Microdose of a Stable Isotopically-Labeled Drug Using a Selected Reaction Monitoring Mass Spectrometry Assay
Hao Jiang et al.
ANALYTICAL CHEMISTRY (2012)
The influence of lipophilicity in drug discovery and design
John A. Arnott et al.
EXPERT OPINION ON DRUG DISCOVERY (2012)
AMPK activation with glabridin ameliorates adiposity and lipid dysregulation in obesity
Joo-Won Lee et al.
JOURNAL OF LIPID RESEARCH (2012)
Applications of stable isotopes in clinical pharmacology
Reinout C. A. Schellekens et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Preclinical pharmacokinetics and bioavailability of noscapine, a tubulin-binding anticancer agent
Ritu Aneja et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
Prodrug strategies to overcome poor water solubility
Valentino J. Stella et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Drug delivery strategies for poorly water-soluble drugs
Alfred Fahr et al.
EXPERT OPINION ON DRUG DELIVERY (2007)
The use of isotopes in the determination of absolute bioavailability of drugs in humans
Graham Lappin et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2006)
Enhanced paclitaxel bioavailability after oral administration of paclitaxel or prodrug to rats pretreated with quercetin
JS Choi et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2004)
Bioavailability and its assessment
PL Toutain et al.
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS (2004)
Bioavailability and metabolism
Wilhelm Stahl et al.
MOLECULAR ASPECTS OF MEDICINE (2002)
Pharmacokinetics of entacapone, a peripherally acting catechol-O-methyltransferase inhibitor, in man - A study using a stable isotope technique
H Heikkinen et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Calculation of isotope effects from first principles
S Scheiner
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2000)
分享论文
